Comparison between 3 surgical treatments in stable vitiligo patients
Not Applicable
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2019/11/021900
- Lead Sponsor
- GCS Medical college Hospital and Research center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other (Terminated)
- Sex
- Not specified
- Target Recruitment
- 6
Inclusion Criteria
1. Patients with stable vitiligo ( no new lesions, no progression of existing lesions for past 1 year)
2. Patients >18 years
Exclusion Criteria
1. Patients with active vitiligo
2. Patients with history of Koebner phenomenon
3. Patients with keloidal tendency
4. Patients with a history of bleeding disorders
5. Presence of concomitant local or systemic infections
6. Presence of uncontrolled diabetes
7. Pregnant or lactating patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response evaluation: <br/ ><br>1.By calculating the percentage area of reduction in the area of vitiligo. <br/ ><br>This will be done at every follow-up. <br/ ><br> <br/ ><br>2.Qualitative assessment: <br/ ><br> <br/ ><br>0-25 â?? poor response (grade 1) <br/ ><br>25-50 â?? fair response (grade 2) <br/ ><br>50-75 â?? good response (grade 3) <br/ ><br>75-100 â?? excellent response (grade 4) <br/ ><br>4. Hair repigmentationTimepoint: Every month after procedure for 3 months
- Secondary Outcome Measures
Name Time Method Occurrence of any side effects including infection, graft loss, healing delay, extension of lesionTimepoint: Every month after procedure for 3 months